Maternal mean arterial pressure and serum inhibin A as early predictors of hypertensive disorders in low‐risk pregnant women attending a University Teaching Hospital in Lagos, Nigeria: A prospective cohort study
International Journal of Gynecology & Obstetrics · 2026-11-12
DOI: 10.1002/ijgo.71418 ↗Abstract
Abstract Objective This study evaluates the role of maternal mean arterial pressure (MAP) and serum inhibin‐A level as early predictors of hypertensive disorders of pregnancy (HDP) among low‐risk pregnant women attending a University Teaching Hospital in Lagos, Nigeria. Methods This was a prospective cohort study of 254 consecutively consenting, low‐risk, normotensive, and non‐proteinuric pregnant women at 13–19 weeks of gestation. Receiver operating characteristics (ROC) curves and validity tests were used to determine the performance of serum levels of inhibin A, MAP, and a combination of both in predicting HDP (gestational hypertension and preeclampsia). Results The mean age and parity of the participants was 30.3 ± 4.9 years and 1 (0–2), respectively. The area under the ROC curves of serum inhibin A (0.9981, 95% confidence interval [CI]: 0.9946–1.000) was higher than for MAP (0.7531, 95% CI 0.6641–0.8421), in predicting the composite endpoint of HDP. The optimum cut‐offs for predicting HDP as calculated from Youden's index were 476.8 pg/mL (sensitivity = 100% and specificity = 98.7%) for serum inhibin A and 81.3 mm Hg (sensitivity = 100% and specificity = 50.1%) for MAP. There was no statistically significant difference between the combined predictive ability of inhibin A and MAP compared to that of serum inhibin A alone for predicting HDP (AUC of 0.9984 vs. 09981, P ‐value = 0.7259. Conclusion This study demonstrated that serum inhibin A alone and MAP have good and moderate performance, respectively, in predicting HDP in the low‐risk cohort of Nigerian pregnant women. The combination of serum inhibin A and MAP has a similar predictive performance as serum inhibin A alone.
EUVIMED